搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
1 小时
Imitation Ozempic Floods Market: Understanding Risks, Costs, and Alternatives
Imitation Ozempic products pose serious health risks to consumers Brand-name Ozempic costs $800-$1,000 per month, limiting ...
2 小时
FDA“三思“将礼来(LLY.US)减肥神药移除短缺名单,Hims & Hers Health(HIMS.US ...
智通财经APP获悉,在美国食品药品监督管理局 (FDA)决定将礼来公司 (LLY.US)的替西帕肽 (Tirzepatide)从药品短缺清单中移除后,一起针对此次除名举措的诉讼引发了Hims & Hers Health (HIMS.US)周一交易上涨 ...
pharmaphorum
2 小时
Lilly pledges £279m to UK for biotech hub and obesity plan
The proposal, unveiled at the government's International Investment Summit today is headlined by the creation of a UK biotech ...
3 小时
Buy Rating Affirmed for LifeMD Amid Favorable Compounding Pharmacy Developments and Strong ...
Analyst David Larsen from BTIG maintained a Buy rating on LifeMD (LFMD – Research Report) and keeping the price target at $12.00. David ...
6 小时
FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
9 小时
Compounding pharmacies can resume making tirzepatide as FDA reconsiders shortage
The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of ...
9 小时
Hold Rating Maintained Amidst Strong Performance and Market Volatility: Glen Santangelo’s ...
Analyst Glen Santangelo of Jefferies maintained a Hold rating on Hims & Hers Health (HIMS – Research Report), with a price target of ...
10 小时
Trump says national abortion ban ‘off the table’
Click in for more news from The Hill{beacon} Health Care Health Care The Big Story Trump hedges on abortion banFormer ...
10 小时
FDA will reconsider decision barring copycat versions of Lilly weight loss drug
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...
11 小时
WeightWatchers Launches $129 Ozempic Alternative Amid Shortages
In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to ...
13 小时
Hims & Hers Stock Soars 7% as FDA Reconsiders Limits on Compounded Weight-Loss Drugs
Hims & Hers Health saw its shares surge by 7% today after the FDA announced that it would reconsider its decision to limit ...
14 小时
FDA, facing pressure, to review position on Zepbound, Mounjaro shortage
The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈